ECP 2025
Our Posters
External Quality Assessment for FGFR3 testing in Urothelial / Bladder cancer
Authors: Victoria Williams, Melanie H Cheetham, Simon J Patton
Learnings from a Pilot External Quality Assessment (EQA) for cfDNA Extraction from Plasma
Authors: Matthew Hellio, Melanie H Cheetham, Victoria S Williams, Simon J Patton
External Quality Assessment (EQA) for Homologous Recombination Deficiency (HRD) testing in ovarian cancer: Findings of a new international Quality Network for Pathology (IQN Path) pilot scheme
Authors: Arfa Maqsood, Victoria Williams, Francesca Fenizia, Jennifer A Fairley, Tracy Stockley, Sze Chai, Etienne Rouleau,Simon J Patton
Our Assessor Vacancies
Molecular Pathology
- Homologous recombination deficiency (HRD) testing
- ESR1 testing in breast cancer cfDNA (plasma)
- Urothelial cell carcinoma (UCC) (FGFR) [Tissue]
- Fusion testing in solid tumour
- Lung Cancer (NSCLC) [Tissue]
- Microsatellite instability (MSI)
- Breast cancer (AKT pathway gene testing (PIK3CA, AKT1, PTEN) [Tissue]
Technical Assessment
- Pharmacogenetics
Genomic & Inherited Disorders
- SAID
- Monodiab
- Polyposis
- MEN2
- PKU
- SMA
- OI
- HD
- Skeletal dysplasia
- Neurofibromatosis
- SHOX
Other Relevant Documents
MSI Placeholder
International society of liquid biopsy (ISLB) perspective on minimal requirements for ctDNA testing in solid tumors
HGVS Nomenclature 2024: improvements to community engagement, usability, and computability
Our Next Webinar
Join Us for the Official Launch of the 2026 EQA Catalogue.
We’re thrilled to invite you to a special Zoom webinar unveiling the 2026 EQA Catalogue.
This session is tailored for genomics professionals and will spotlight key updates, exciting new offerings, and how our programmes can support your lab’s quality assurance goals in the year ahead.
This session is tailored for genomics professionals and will spotlight key updates, exciting new offerings, and how our programmes can support your lab’s quality assurance goals in the year ahead.
We hope to see you there!